Page last updated: 2024-09-05

rs 127445 and sb 215505

rs 127445 has been researched along with sb 215505 in 2 studies

Compound Research Comparison

Studies
(rs 127445)
Trials
(rs 127445)
Recent Studies (post-2010)
(rs 127445)
Studies
(sb 215505)
Trials
(sb 215505)
Recent Studies (post-2010) (sb 215505)
291181108
291181202

Protein Interaction Comparison

ProteinTaxonomyrs 127445 (IC50)sb 215505 (IC50)
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0385

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Raziq, MS; Gabr, MT1
Choi, Y; Cogan, D; Flegg, A; Kahrs, A; Loke, P; Meyn, O; Moss, N; Nagaraja, R; Napier, S; Parker, A; Ramsden, P; Sarko, C; Skow, D; Thomas Peterson, J; Tomlinson, J; Tye, H; Whitaker, M1

Other Studies

2 other study(ies) available for rs 127445 and sb 215505

ArticleYear
Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists.
    MedChemComm, 2018, Jun-01, Volume: 9, Issue:6

    Topics:

2018
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties.
    Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8

    Topics: Animals; Binding Sites; Male; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2009